HUP0002691A2 - Ciklezonid tartalmú gyógyászati aeroszol termékek - Google Patents

Ciklezonid tartalmú gyógyászati aeroszol termékek

Info

Publication number
HUP0002691A2
HUP0002691A2 HU0002691A HUP0002691A HUP0002691A2 HU P0002691 A2 HUP0002691 A2 HU P0002691A2 HU 0002691 A HU0002691 A HU 0002691A HU P0002691 A HUP0002691 A HU P0002691A HU P0002691 A2 HUP0002691 A2 HU P0002691A2
Authority
HU
Hungary
Prior art keywords
ciclesonide
products containing
aerosol products
medicinal aerosol
containing ciclesonide
Prior art date
Application number
HU0002691A
Other languages
English (en)
Inventor
Kanu M. Fatania
Helgert Muller
Martin J. Oliver
John S. Scott
Original Assignee
Minnesota Mining And Manufacturing Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710496.2A external-priority patent/GB9710496D0/en
Priority claimed from GBGB9803990.2A external-priority patent/GB9803990D0/en
Application filed by Minnesota Mining And Manufacturing Co. filed Critical Minnesota Mining And Manufacturing Co.
Publication of HUP0002691A2 publication Critical patent/HUP0002691A2/hu
Publication of HUP0002691A3 publication Critical patent/HUP0002691A3/hu
Publication of HU226694B1 publication Critical patent/HU226694B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

A találmány orális és/vagy nazális inhalálásra alkalmas gyógyászatiaeroszolkészítményre vonatkozik, amely ciklezonid gyulladásellenesszert, fluorozott szénhidrogén hajtógázt, így HFC 134a-t és/vagy 227-et és a ciklezonid szolubilizálásához elegendő mennyiségben etanolt(valamint adott esetben különféle komponenseket, így felületaktívanyagot) tartalmaz. Ó
HU0002691A 1997-05-21 1998-05-18 Medicinal aerosol products containing ciclesonide HU226694B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710496.2A GB9710496D0 (en) 1997-05-21 1997-05-21 Medicinal aerosol products
GBGB9803990.2A GB9803990D0 (en) 1998-02-25 1998-02-25 Medicinal aerosol products
PCT/US1998/010155 WO1998052542A1 (en) 1997-05-21 1998-05-18 Medicinal aerosol products

Publications (3)

Publication Number Publication Date
HUP0002691A2 true HUP0002691A2 (hu) 2001-02-28
HUP0002691A3 HUP0002691A3 (en) 2001-04-28
HU226694B1 HU226694B1 (en) 2009-06-29

Family

ID=26311564

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002691A HU226694B1 (en) 1997-05-21 1998-05-18 Medicinal aerosol products containing ciclesonide

Country Status (28)

Country Link
US (1) US6120752A (hu)
EP (1) EP0983058B1 (hu)
JP (4) JP2001526685A (hu)
KR (1) KR100527643B1 (hu)
CN (1) CN1149073C (hu)
AT (1) ATE245966T1 (hu)
AU (1) AU726835B2 (hu)
BG (1) BG64268B1 (hu)
BR (1) BR9809448A (hu)
CA (1) CA2290521C (hu)
CZ (1) CZ298253B6 (hu)
DE (1) DE69816811T2 (hu)
DK (1) DK0983058T3 (hu)
EA (1) EA002381B1 (hu)
ES (1) ES2205491T3 (hu)
HK (1) HK1027027A1 (hu)
HU (1) HU226694B1 (hu)
IL (1) IL132738A (hu)
ME (1) ME01631B (hu)
NO (2) NO327716B1 (hu)
NZ (1) NZ500874A (hu)
PL (1) PL191523B1 (hu)
PT (1) PT983058E (hu)
RS (1) RS49628B (hu)
SK (1) SK283930B6 (hu)
TR (1) TR199902863T2 (hu)
UA (1) UA58551C2 (hu)
WO (1) WO1998052542A1 (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
US20040235811A1 (en) * 2002-10-08 2004-11-25 Sepracor Inc. Fatty acid modified forms of glucocorticoids
EP2314653A3 (en) * 2002-10-25 2014-07-23 Honeywell International Inc. Compositions containing fluorine substituted olefins
PT1572217E (pt) * 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
US8435497B2 (en) 2003-06-13 2013-05-07 Takeda Gmbh Formoterol of and ciclesonide combination
PL1670482T5 (pl) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
GB2406283B (en) 2003-09-24 2006-04-05 Altana Pharma Ag Compliance monitor and method
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
CN103462894A (zh) * 2005-03-16 2013-12-25 霍尼韦尔国际公司 药物递送制剂、装置和方法
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
CA2677838C (en) 2007-02-11 2017-08-01 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
CA2754589C (en) * 2009-03-09 2013-07-16 Mikasa Seiyaku Co., Ltd. Steroid compound
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
RU2642624C2 (ru) * 2010-10-12 2018-01-25 Сипла Лимитед Фармацевтическая композиция
US11007150B2 (en) * 2011-08-18 2021-05-18 Covis Pharma Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation
CN102335132A (zh) * 2011-10-12 2012-02-01 中山大学 一种细辛脑吸入气雾剂及其制备方法
US20150010527A1 (en) 2012-02-01 2015-01-08 Protalix Ltd. Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077229B (en) * 1980-05-16 1983-08-03 Neotechnic Eng Ltd Valve assembly for a pressurized aerosoldispensing container
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69131867T2 (de) * 1990-03-23 2000-05-18 Minnesota Mining & Mfg Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
DK0553298T3 (da) * 1990-10-18 1995-04-18 Minnesota Mining & Mfg Aerosolformulering omfattende beclomethason-17,21-dipropionat
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
DE69424181T2 (de) * 1993-12-20 2000-10-19 Minnesota Mining & Mfg Flunisolide aerosolformulierungen
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
BR9604976A (pt) * 1995-04-14 1998-06-09 Glaxo Wellcome Inc Inalador de dose medida sistema inalador de dose medida e uso do mesmo
NZ306281A (en) * 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
ATE250439T1 (de) * 1995-04-14 2003-10-15 Smithkline Beecham Corp Dosierinhalator für salmeterol

Also Published As

Publication number Publication date
BR9809448A (pt) 2000-06-20
CA2290521C (en) 2006-10-10
CZ412499A3 (cs) 2000-02-16
NZ500874A (en) 2001-09-28
JP6087882B2 (ja) 2017-03-01
CA2290521A1 (en) 1998-11-26
JP2016169222A (ja) 2016-09-23
AU7496298A (en) 1998-12-11
JP2011102301A (ja) 2011-05-26
PL191523B1 (pl) 2006-06-30
EA199900991A1 (ru) 2000-08-28
DE69816811T2 (de) 2004-04-15
RS49628B (sr) 2007-08-03
EP0983058B1 (en) 2003-07-30
KR20010012810A (ko) 2001-02-26
DK0983058T3 (da) 2003-11-24
CZ298253B6 (cs) 2007-08-08
CN1257421A (zh) 2000-06-21
TR199902863T2 (xx) 2000-05-22
BG64268B1 (bg) 2004-08-31
JP2001526685A (ja) 2001-12-18
BG103902A (en) 2000-05-31
US6120752A (en) 2000-09-19
NO327716B1 (no) 2009-09-14
NO995667D0 (no) 1999-11-18
AU726835B2 (en) 2000-11-23
IL132738A0 (en) 2001-03-19
YU59899A (sh) 2002-06-19
SK157699A3 (en) 2000-05-16
CN1149073C (zh) 2004-05-12
EP0983058A1 (en) 2000-03-08
JP6178459B2 (ja) 2017-08-09
HU226694B1 (en) 2009-06-29
EA002381B1 (ru) 2002-04-25
NO2009024I2 (no) 2010-08-16
PT983058E (pt) 2003-12-31
UA58551C2 (uk) 2003-08-15
IL132738A (en) 2004-06-20
ATE245966T1 (de) 2003-08-15
WO1998052542A1 (en) 1998-11-26
HK1027027A1 (en) 2001-01-05
PL336885A1 (en) 2000-07-17
ME01631B (me) 2007-08-03
HUP0002691A3 (en) 2001-04-28
JP2015024999A (ja) 2015-02-05
DE69816811D1 (de) 2003-09-04
ES2205491T3 (es) 2004-05-01
SK283930B6 (sk) 2004-05-04
KR100527643B1 (ko) 2005-11-15
NO995667L (no) 1999-11-18
NO2009024I1 (no) 2009-10-26

Similar Documents

Publication Publication Date Title
HUP0002691A2 (hu) Ciklezonid tartalmú gyógyászati aeroszol termékek
DE69231994D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
AU4260496A (en) Propellant mixture for aerosol formulation
CY1109212T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα
ES2064160T3 (es) Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
DE69721020D1 (de) Nichtpolares nitroglycerinspray zur bukkalen verabreichung
AU4346996A (en) Pharmaceutical aerosol containing at least one sugar
IL153726A0 (en) Novel aerosol formulation containing a polar fluorinated molecule
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
GB2332372B (en) Pharmaceutical aerosol compositions
MX9707238A (es) Formulaciones en aerosol de butixocort.

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: NYCOMED GMBH, DE

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; ALTANA PHARMA AG, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; ALTANA PHARMA AG, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US

AA1S Information on application for a supplementary protection certificate

Free format text: PRODUCT NAME: CICLESONIDE; REG. NO/DATE: OGYI-T-9971/01-OGYI-T-9973/01 20041221; FIRST REG.: GB PL20141/0004-0006 20040416

Spc suppl protection certif: S0900014

Filing date: 20090818

Expiry date: 20180518

FG4S Grant of supplementary protection certificate

Free format text: PRODUCT NAME: CICLESONIDE; REG. NO/DATE: OGYI-T-9971/01-OGYI-T-9973/01 20041221; FIRST REG.: GB PL20141/0004-0006 20040416

Spc suppl protection certif: S0900014

Filing date: 20090818

Expiry date: 20180518

Extension date: 20190417

HC9A Change of name, address

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE

Owner name: TAKEDA GMBH, DE

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE

GB9A Succession in title

Owner name: TAKEDA GMBH, DE

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; TAKEDA GMBH, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Free format text: FORMER OWNER(S): MINNESOTA MINING AND MANUFACTURING CO., US; TAKEDA GMBH, DE; 3M COMPANY, US; 3M INNOVATIVE PROPERTIES COMPANY, US; ALTANA PHARMA AG, DE; NYCOMED GMBH, DE